Literature DB >> 12106199

Noradrenergic Control of Thalamic Oscillation: the Role of alpha-2 Receptors.

G. Buzsáki1, B. Kennedy, V. B. Solt, M. Ziegler.   

Abstract

The effects of alpha-adrenergic drugs on neocortical high voltage spike and wave spindles (HVS), reflecting thalamic oscillation, was investigated in freely moving rats. HVS occurred spontaneously in the awake but immobile animal. Peripheral administration of the alpha-1 antagonist, prazosin and alpha-2 agonists, xylazine and clonidine increased the incidence and duration of HVS in a dose-dependent manner. The alpha-2 antagonist, yohimbine and the tricyclic antidepressants, desipramine and amitriptyline, significantly decreased the incidence of the neocortical HVS. Bilateral microinjections of the alpha-2 agonists into the nucleus ventralis lateralis area of the thalamus, but not into the hippocampus or corpus callosum, was as effective as peripheral injection of these drugs. Xylazine was most effective in Fischer 344 rats that display high spontaneous rate of HVS and less effective in the Sprague - Dawley and Buffalo strains. The HVS-promoting effect of clonidine was antagonized by prior intrathalamic injection of the alpha-2 antagonist, yohimbine. The amplitude of the HVS was increased by picomole amounts of unilaterally-injected clonidine. Neurotoxic destruction of the thalamopetal noradrenergic afferents by intracisternal or intrathalamic injection of 6-hydroxydopamine, but not by peripheral administration of DSP-4, increased the incidence of HVS. Importantly, intrathalamic administration of xylazine continued to induce HVS after destroying the thalamic noradrenergic terminals. Following downregulation of the alpha-2 adrenoceptors by chronic administration (3 weeks) of amitriptylene the incidence of HVS decreased and the effectiveness of intrathalamic xylazine on the induction of HVS was significantly reduced. Based on these findings, we suggest that a major action of alpha-2 adrenergic drugs on thalamic oscillation may be mediated by postsynaptic alpha-2 adrenoceptors located on the thalamocortical neurons. We hypothesize that noradrenaline in the thalamus has a dual effect on the relay cells: blocking and promoting thalamic oscillation via alpha-1 and alpha-2 receptors, respectively. The final physiological effect is assumed to be a function of the relative density and affinity of these adrenergic receptor subtypes.

Entities:  

Year:  1991        PMID: 12106199     DOI: 10.1111/j.1460-9568.1991.tb00083.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  20 in total

Review 1.  The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Amy F T Arnsten
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

2.  The alpha-2B adrenoceptor in the paraventricular thalamic nucleus is persistently upregulated by chronic psychosocial stress.

Authors:  U Heilbronner; M van Kampen; G Flügge
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

3.  Focal generation of paroxysmal fast runs during electrographic seizures.

Authors:  Sofiane Boucetta; Sylvain Chauvette; Maxim Bazhenov; Igor Timofeev
Journal:  Epilepsia       Date:  2008-06-26       Impact factor: 5.864

Review 4.  Clonidine extended-release: in attention-deficit hyperactivity disorder.

Authors:  Jamie D Croxtall
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

5.  The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.

Authors:  Amy F T Arnsten
Journal:  J Pediatr       Date:  2009-05-01       Impact factor: 4.406

6.  Pharmacological Modulation of Noradrenergic Arousal Circuitry Disrupts Functional Connectivity of the Locus Ceruleus in Humans.

Authors:  Andrew H Song; Aaron Kucyi; Vitaly Napadow; Emery N Brown; Marco L Loggia; Oluwaseun Akeju
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

7.  On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists.

Authors:  Tommy Pattij; Dustin Schetters; Anton N M Schoffelmeer; Marcel M van Gaalen
Journal:  Psychopharmacology (Berl)       Date:  2011-07-19       Impact factor: 4.530

8.  Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.

Authors:  Christian Pifl; Stephen J Kish; Oleh Hornykiewicz
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

Review 9.  Electrical stimulation of cranial nerves in cognition and disease.

Authors:  Devin Adair; Dennis Truong; Zeinab Esmaeilpour; Nigel Gebodh; Helen Borges; Libby Ho; J Douglas Bremner; Bashar W Badran; Vitaly Napadow; Vincent P Clark; Marom Bikson
Journal:  Brain Stimul       Date:  2020-02-23       Impact factor: 8.955

10.  [N-methyl-11C]Mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humans.

Authors:  Katalin Marthi; Steen Jakobsen; Dirk Bender; Søren B Hansen; Stefan Bo Smith; Flemming Hermansen; Raben Rosenberg; Donald F Smith
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.